Curbside Consultation in Glaucoma: 49 Clinical Questions 1st Edition

“The active clinician will find the answer to most major questions that may be posed in the management of the glaucoma patient, and the usefulness of the answers is rewarding. I think the ophthalmic generalist and probably some glaucoma specialists would do well to study this book, and I recommend this approach for the next addition to the bookshelf of the active clinician.”

— Richard Bensinger, MD, Seattle, WA, Ocular Surgery News  

“This concise reference helps general ophthalmologists in arranging treatment plans for their glaucoma patients. Its unique question and answer format allows for easy retention. This book is helpful in the understanding and treatment of glaucoma, since it is an evolving field. The diagnostic tools are particularly well covered, with great illustrations and explanations. This is a great resource for general ophthalmologists seeing glaucoma patients. The stepwise question and answer format makes reading easy. It answers common questions and eases the anxiety factor that accompanies some of the uncertainty in glaucoma management.”

— Sanjay N. Smith, MD, University of Pennsylvania School of Medicine, Doody Enterprises, Inc.

Dale K. Heuer, MD received his undergraduate and medical degrees from Northwestern University. He completed his ophthalmology residency at the Medical College of Wisconsin and a 2-year National Research Service Award–funded glaucoma fellowship at the Bascom Palmer Eye Institute. Dr. Heuer has published extensively on the use of conventional filtering procedures with wound-healing modulation and aqueous shunting procedures for t he management of glaucomas with poor surgical prognoses. He has participated in several glaucoma clinical trials, including the Fluorouracil Filtering Surgery Study, the Collaborative Normal-Tension Glaucoma Study, and the Collaborative Initial Glaucoma Study. Dr. Heuer currently serves as one of the three Vice Chairs of the National Eye Institute–sponsored Ocular Hypertension Treatment Study, one of the three Co-Chairs of the Tube Versus Trabeculectomy Study, a member of the Safety & Data Monitoring Committee of the Ahmed-Baerveldt Comparison Study, and a voting member of the US Food & Drug Administration’s Ophthalmic Device Panel. He is Professor and Chairman of Ophthalmology at the Medical College of Wisconsin, where he also serves as the Director of the Froedtert & Medical College of Wisconsin Eye Institute.